Metraipolis › archive › dc_f9840be2b52b

Detection of drug resistant Mycobacterium tuberculosis by high-throughput sequencing of DNA isolated from acid fast bacilli smears — Europe PMC PMID:32384098

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/32384098
DOI
10.1371/journal.pone.0232343
License (as archived)
CC0-1.0
Archived
2026-11-08T18:20:36.899Z
SHA-256 of the archived text
690defda3b07b9d18d0ed986d7d8170e1d4e1b99498dd7f51efca8465835927c
Stable URL of this page
https://metraipolis.com/documento/dc_f9840be2b52b

How to cite

Detection of drug resistant Mycobacterium tuberculosis by high-throughput sequencing of DNA isolated from acid fast bacilli smears — Europe PMC PMID:32384098 — Europe PMC (en), https://europepmc.org/article/MED/32384098 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_f9840be2b52b (Metraipolis archive dc_f9840be2b52b, sha256 690defda3b07b9d18d0ed986d7d8170e1d4e1b99498dd7f51efca8465835927c)
BibTeX
@misc{dcf9840be2b52b,
  title = {Detection of drug resistant Mycobacterium tuberculosis by high-throughput sequencing of DNA isolated from acid fast bacilli smears — Europe PMC PMID:32384098},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/32384098},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_f9840be2b52b; sha256 690defda3b07b9d18d0ed986d7d8170e1d4e1b99498dd7f51efca8465835927c},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32384098. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Drug susceptibility testing for Mycobacterium tuberculosis (MTB) is difficult to perform in resource-limited settings where Acid Fast Bacilli (AFB) smears are commonly used for disease diagnosis and monitoring. We developed a simple method for extraction of MTB DNA from AFB smears for sequencing-based detection of mutations associated with resistance to all first and several second-line anti-tuberculosis drugs. Methods: We isolated MTB DNA by boiling smear content in a Chelex solution, followed by column purification. We sequenced PCR-amplified segments of the rpoB, katG, embB, gyrA, gyrB, rpsL, and rrs genes, the inhA, eis, and pncA promoters and the entire pncA gene. Results: We tested our assay on 1,208 clinically obtained AFB smears from Ghana (n = 379), Kenya (n = 517), Uganda (n = 262), and Zambia (n = 50). Coverage depth varied by target and slide smear grade, ranging from 300X to 12000X on average. Coverage of ≥20X was obtained for all targets in 870 (72%) slides overall. Mono-resistance (5.9%), multi-drug resistance (1.8%), and poly-resistance (2.4%) mutation profiles were detected in 10% of slides overall, and in over 32% of retreatment and follow-up cases. Conclusion: This rapid AFB smear DNA-based method for determining drug resistance may be useful for the diagnosis and surveillance of drug-resistant tuberculosis.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2020 (prima pubblicazione 2020-05-08).
Identificativi: PMID 32384098 · PMCID PMC7209238 · DOI 10.1371/journal.pone.0232343.
Descrittori MeSH principali: High-Throughput Nucleotide Sequencing.
Pagina: https://europepmc.org/article/MED/32384098 — https://doi.org/10.1371/journal.pone.0232343. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-08T18:17:00.172Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.